Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Dundee Corp T.DC.A

Alternate Symbol(s):  DDEJF

Dundee Corporation is a Canada-based holding company. Through its operating segments, the Company is a mining- focused investor primarily engaged in acquiring mineral resource assets. Its segments include mining investments, mining services, and corporate and others. Its asset base includes investments in precious and base metals projects across four continents. Its subsidiaries include Dundee Sustainable Technologies Inc. (Dundee Technologies), Dundee Resources Limited, and Goodman & Company, Investment Counsel Inc. The Dundee Sustainable Technologies Inc., a 78%-owned subsidiary developing patented sustainable precious and base metals extraction processes. Through the development of its patented processes, the GlassLock Process and the CLEVR Process, Dundee Technologies extracts precious and base metals from ores and concentrates, while stabilizing contaminants such as arsenic.


TSX:DC.A - Post by User

Comment by Catscratchon Jan 09, 2024 9:00am
108 Views
Post# 35817037

RE:RE:RE:In the meantime, Genting is moving up

RE:RE:RE:In the meantime, Genting is moving upHere's some recent commentary on TauRx from a Genting analyst...

It is worth noting that Genting has a call option in its 20%-owned TauRx Pharmaceuticals Ltd, which is developing a drug to combat Alzheimer's disease.

It is understood that TauRx has submitted its lead investigative drug hydromethylthionine mesylate (HMTM) for consideration for approval in the UK via the Medicines and Healthcare Products Regulatory Agency.

“We currently value TauRx at only US$1 billion (RM4.65 billion). Our TP for Genting may be revised to over RM8 should TauRx be valued at US$15 billion as once widely reported,” said Maybank IB, which maintains its "buy" call for Genting with a higher TP of RM5.84 (from RM5.49).

https://theedgemalaysia.com/node/696539
<< Previous
Bullboard Posts
Next >>